Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Asperger Syndrome Companies

ID: MRFR/Pharma/4383-HCR
100 Pages
Vikita Thakur
Last Updated: February 16, 2025
Asperger's Syndrome is no longer officially recognized as a separate diagnosis from Autism Spectrum Disorder (ASD) according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). However, individuals who were previously diagnosed with Asperger's Syndrome are often still identified as having traits associated with high-functioning autism within the broader spectrum.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Asperger Syndrome Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)8.37%
2024 Market Size$ 2,387.09 Million
2025 Market Size$ 2,614.25 Million
2035 Market Size$ 5,803.86 Million
Key Players
Autism Speaks
National Autistic Society
Asperger/Autism Network
Autism Society
Autism Research Institute
The Autism Community in Action
Opportunities
  • Growing Research and Development
  • Government Initiatives and Funding
  • Increasing Awareness and Diagnosis

Top Industry Leaders in the Asperger Syndrome Market

Asperger
 

Latest Asperger Syndrome Companies Updates:

Akili Interactive Labs receives FDA approval for EndeavorRx This video game-based therapy received approval for improving attention function in children with ASD aged 8-12 years old. This marks a significant advancement in using digital therapeutics for ASD intervention.

Studies on AI-powered tools Companies are actively researching AI-powered tools to analyze language, facial expressions, and eye movements for early detection of ASD in children. Early detection and intervention is crucial for improving long-term outcomes.

List of Asperger Syndrome Key companies in the market:

  • Eli Lilly and company
  • Shire
  • Jazz Pharmaceuticals
  • Pfizer
  • GlaxoSmithKline
  • Forest laboratories
  • Johnson & Johnson
  • Bristol-Myers Squibb
  • Otsuka pharmaceutical
  • AstraZeneca